Results
Inspire Medical Beats Estimates, Stock Rises 27%
Inspire Medical Systems reported Q2 revenue of $200.6 million and adjusted EPS of $0.14, a +158.3% surprise versus a $0.24 loss forecast.
Adjusted EBITDA beat expectations by 40%; management lifted FY
